Microbial Identification Market – By Product and Services (Instrument [PCR, Mass Spectrometer], Consumable, Software, Service), Method (Phenotypic, Genotypic), Application (Clinical Diagnostics, Pharmaceuticals), End-use – Global Forecast (2024 – 2032)

Report Content Chapter 1 Methodology & Scope 1.1 Market scope & definitions 1.2 Research design 1.2.1 Research approach 1.2.2 Data collection methods 1.3 Base estimates & calculations 1.3.1 Base year calculation 1.3.2 Key trends for market estimation 1.4 Forecast model 1.5 Primary research and validation 1.5.1 Primary sources 1.5.2 Data mining sources Chapter 2 Executive Summary 2.1 Industry 360 degree synopsis Chapter 3 Industry Insights 3.1 Industry ecosystem analysis 3.2 Industry impact forces 3.2.1 Growth drivers 3.2.1.1 Increasing prevalence of infectious diseases 3.2.1.2 Rising technological advancements 3.2.1.3 Increasing awareness about food safety 3.2.2 Industry pitfalls & challenges 3.2.2.1 High cost of automated microbial identification systems 3.3 Growth potential analysis 3.4 Regulatory landscape 3.5 Technological landscape 3.6 Porter's analysis 3.7 PESTEL analysis Chapter 4 Competitive Landscape, 2023 4.1 Introduction 4.2 Company market share analysis 4.3 Competitive positioning matrix 4.4 Strategy outlook matrix Chapter 5 Market Estimates and Forecast, By Product and Services, 2021 - 2032 ($ Mn) 5.1 Key trends 5.2 Instruments 5.2.1 Mass spectrometers 5.2.2 PCR systems 5.2.3 Microarrays 5.2.4 Other instruments 5.3 Consumables 5.3.1 Reagents and kits 5.3.2 Plates and media 5.4 Software 5.5 Services Chapter 6 Market Estimates and Forecast, By Method, 2021 - 2032 ($ Mn) 6.1 Key trends 6.2 Phenotypic methods 6.3 Genotypic methods 6.4 Proteotypic methods Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn) 7.1 Key trends 7.2 Clinical diagnostics 7.3 Pharmaceuticals 7.4 Cosmetic and personal care product testing 7.5 Food and beverage testing 7.6 Environmental application 7.7 Other applications Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn) 8.1 Key trends 8.2 Pharmaceutical and biotechnology companies 8.3 Hospitals and diagnostic laboratories 8.4 Food testing laboratories 8.5 Other end-users Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn) 9.1 Key trends 9.2 North America 9.2.1 U.S. 9.2.2 Canada 9.3 Europe 9.3.1 Germany 9.3.2 UK 9.3.3 France 9.3.4 Spain 9.3.5 Italy 9.3.6 Netherlands 9.3.7 Rest of Europe 9.4 Asia Pacific 9.4.1 Japan 9.4.2 China 9.4.3 India 9.4.4 Australia 9.4.5 South Korea 9.4.6 Rest of Asia Pacific 9.5 Latin America 9.5.1 Brazil 9.5.2 Mexico 9.5.3 Argentina 9.5.4 Rest of Latin America 9.6 Middle East and Africa 9.6.1 Saudi Arabia 9.6.2 South Africa 9.6.3 UAE 9.6.4 Rest of Middle East and Africa Chapter 10 Company Profiles 10.1 Avantor, Inc. 10.2 bioMérieux SA 10.3 Becton, Dickinson and Company 10.4 Bruker Corporation 10.5 Beckman Coulter, Inc. 10.6 Biolog, Inc. 10.7 Charles River Laboratories International, Inc. 10.8 Eurofins Scientific 10.9 Merck KGaA 10.10 Qiagen N.V. 10.11 Shimadzu Corporation 10.12 Thermo Fisher Scientific Inc. 10.13 Wickham Micro Limited